J&J Argument Against Liver Damage Experts 'Borders On Ridiculous' – Judge
This article was originally published in The Pink Sheet & The Rose Sheet
Executive Summary
J&J fails in request to exclude two experts for the plaintiff in bellwether litigation alleging liver damage from indicated doses of Tylenol Extra Strength. The decision represents the second blow in less than a month in J&J's efforts to exclude plaintiff's evidence from the trial.
You may also be interested in...
Judge Slams J&J Spin On Study Suggesting Acetaminophen-Induced Liver Damage
Johnson & Johnson should address perceived flaws in evidence supporting liver damage by acetaminophen in cross-examination instead of trying to exclude the evidence, says the federal judge overseeing a suit alleging liver damage from use of Tylenol Extra Strength.
Judge Rejects Prior Restraint For Tylenol Ads Ahead Of 'Bellwether' Trial
J&J/McNeil may continue to advertise the Tylenol line ahead of the first case in multi-district litigation claiming use of the products as labeled is linked to liver damage, says a federal judge. The plaintiff asked the court to prohibit the firm from advertising that could taint the juror pool ahead of the fall trial.
"Acetaminophen poisoning" suit judgment awarded to McNeil by Florida jury.
"ACETAMINOPHEN POISONING" SUIT JUDGMENT AWARDED TO McNEIL by a recent jury verdict in Tampa, Fla. In the case of Domke v. McNeil, "it is ordered and adjudged that plaintiffs take nothing, that the action be dismissed on the merits, and that each party bear its own costs of the action," the verdict states. The plaintiff, Rose Domke, representing her deceased husband, alleged that McNeil failed to warn consumers who regularly consume alcohol about the potential risk of taking acetaminophen. The suit is one of a number of cases claiming "acetaminophen poisoning" among regular drinkers of alcohol.